SIRT1720 promotes survival of corneal epithelial cells via the P53 pathway.
Hayder AbdulHasan JalilBasma Talib Al-SudaniGhaith Ali Jasim
Published in: Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique (2022)
induces oxidative stress-associated cell damage. The results also encouraged us to consider using SRT1720 to improve corneal safety and reduce the adverse effects of oxidative damage.